Assessing genomic diversity and signatures of selection in Pinan cattle using whole-genome sequencing data
2022 · BMC Genomics · 53 citations
https://doi.org/10.1186/s12864-022-08645-y
X
Xinmiao Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
197
Citations
8
h-index
6
i10-index
Xinmiao Li is an academic researcher from Zhejiang Hospital. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Ferroptosis and cancer prognosis & Cancer-related molecular mechanisms research. The author has an h-index of 8, co-authored 16 publications.
ORCID: 0000-0001-7372-8260Papers by this author
worksGinsenoside Rb1 induces hepatic stellate cell ferroptosis to alleviate liver fibrosis via the BECN1/SLC7A11 axis
2023 · Journal of Pharmaceutical Analysis · 24 citations
https://doi.org/10.1016/j.jpha.2023.11.009
LncRNA-MIAT activates hepatic stellate cells via regulating Hippo pathway and epithelial-to-mesenchymal transition
2023 · Communications Biology · 13 citations
https://doi.org/10.1038/s42003-023-04670-z
ALOX15-Driven Ferroptosis: The key target in Dihydrotanshinone I’s epigenetic Battle in hepatic stellate cells against liver fibrosis
2024 · International Immunopharmacology · 9 citations
https://doi.org/10.1016/j.intimp.2024.113827
Serum ribonucleotide reductase M2 is a potential biomarker for diagnosing and monitoring liver fibrosis in chronic hepatitis B patients
2023 · Journal of Medical Virology · 2 citations
https://doi.org/10.1002/jmv.29157
Clinical effect of transcatheter arterial chemoembolization combined with ultrasound-guided radiofrequency ablation in the treatment of liver cancer
2025 · Asian Journal of Surgery · 0 citations
https://doi.org/10.1016/j.asjsur.2025.02.276
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat